What is Vanda Pharmaceuticals' stock symbol?
Vanda Pharmaceuticals trades on the NASDAQ under the ticker symbol "VNDA."
Where is Vanda Pharmaceuticals' stock going? Where will Vanda Pharmaceuticals' stock price be in 2017?
6 brokers have issued 12 month target prices for Vanda Pharmaceuticals' stock. Their predictions range from $18.00 to $24.00. On average, they expect Vanda Pharmaceuticals' share price to reach $21.33 in the next twelve months.
When will Vanda Pharmaceuticals announce their earnings?
Vanda Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Tuesday, May, 2nd 2017.
Who owns Vanda Pharmaceuticals stock?
Vanda Pharmaceuticals' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Palo Alto Investors LLC (9.56%), Patrick Lee, MD (9.56%), Deerfield Management Co. (7.79%), State Street Corp (3.99%), FMR LLC (2.27%) and Integrated Core Strategies (US) LLC (2.10%). Company insiders that own Vanda Pharmaceuticals stock include James E Flynn, James Patrick Kelly, Mihael Hristos Polymeropoulos, Paolo Baroldi, Richard L Gulino and Richard W Dugan.
Who sold Vanda Pharmaceuticals stock? Who is selling Vanda Pharmaceuticals stock?
Vanda Pharmaceuticals' stock was sold by a variety of institutional investors in the last quarter, including Kingdon Capital Management L.L.C., Oxford Asset Management, Acuta Capital Partners LLC, Bogle Investment Management L P DE, Allianz Asset Management AG, Deerfield Management Co., State Board of Administration of Florida Retirement System and RidgeWorth Capital Management LLC. Company insiders that have sold Vanda Pharmaceuticals stock in the last year include James E Flynn and Richard L Gulino.
Who bought Vanda Pharmaceuticals stock? Who is buying Vanda Pharmaceuticals stock?
Vanda Pharmaceuticals' stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Numeric Investors LLC, Russell Investments Group Ltd., State Street Corp, Axiom International Investors LLC DE, Renaissance Technologies LLC, Castleark Management LLC and Palo Alto Investors LLC.
How do I buy Vanda Pharmaceuticals stock?
Shares of Vanda Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Vanda Pharmaceuticals stock cost?
One share of Vanda Pharmaceuticals stock can currently be purchased for approximately $13.85.